Sonnet BioTherapeutics (SONN) Misses Q4 EPS by 31c

February 14, 2024 7:43 AM

Sonnet BioTherapeutics (NASDAQ: SONN) reported Q4 EPS of ($0.31).

For earnings history and earnings-related data on Sonnet BioTherapeutics (SONN) click here.